Management of Non-Colorectal Digestive Cancers with Microsatellite Instability

Area of Science:

• Oncology
• Genetics
• Immunotherapy

Background:

• Microsatellite instability (MSI) is a key indicator of DNA damage, often resulting from impaired DNA mismatch repair.
• MSI detection via genetic sequencing or immunohistochemistry shows high concordance.
• MSI presence in tumors correlates with high neoantigen load, predicting a positive response to immune checkpoint inhibitors (ICIs).

Purpose of the Study:

• To review the predictive and prognostic value of MSI status in non-colorectal digestive cancers.
• To discuss clinical trials of ICIs in these cancers.
• To explore strategies for overcoming immunotherapy resistance.

Main Methods:

• Literature review of translational studies and clinical trials.
• Analysis of MSI detection methods (genetic sequencing, immunohistochemistry).
• Evaluation of MSI's role as a predictive biomarker for ICIs.

Main Results:

• MSI is a predictive biomarker for ICIs in gastrointestinal cancers, with variable clinical utility based on tumor type.
• Tumor microenvironment complexity influences MSI's prognostic impact.
• Recent studies highlight the importance of the tumor microenvironment in immunotherapy response.

Conclusions:

• MSI status holds significant predictive and prognostic value in non-colorectal digestive cancers.
• Understanding tumor microenvironment is crucial for optimizing ICI therapy.
• Further research is needed to develop strategies to overcome ICI resistance.